Vertex Pharmaceuticals stock price (VRTX) fell in the intraday levels while seeking a bottom to send it higher, amid the dominance of the main upward trend in the medium term while trading alongside the secondary short-term trend line.

The stock is buyed by positive pressure because of trading above the 50-day SMA, while the RSI reached oversold levels compared to the stocks movements.

Therefore we expect the stock to return higher, targeting the resistance of $486.40, provided the support of $448.40 holds on.

Trend forecast: Likely Bullish